Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

12.33

+0.36 (3.01%)

At close: Aug 13, 2026, 4:00 PM EDT

11.87

-0.46 (-3.73%)

Pre-market: Aug 14, 2026, 4:01 AM EDT

Telix Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	141.87	440	83.95	79.16	16.02
Cash & Short-Term Investments	141.87	440	83.95	79.16	16.02
Cash Growth	-67.76%	424.12%	6.05%	394.22%	-73.31%
Accounts Receivable	129.2	86.93	44.13	26.78	14.12
Inventory	37.08	23.62	11.79	5.77	2.51
Other Current Assets	22.13	19.57	18.52	6.17	1.91
Total Current Assets	330.28	570.12	158.38	117.89	34.56
Net Property, Plant & Equipment	115.61	33.65	20.77	12.82	4.6
Other Intangible Assets	592.82	257.86	74.7	40.14	40.51
Long-Term Investments	37.09	34.75	8.35	-	-
Other Long-Term Assets	88.18	44.01	14.33	2.92	0.15
Total Assets	1,164	940.38	276.54	173.77	79.82

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	150.35	86.79	55.66	33.7	13.84
Accrued Expenses	50.11	44.23	22.53	10.12	3.46
Current Portion of Long-Term Debt	13.11	11.76	0.66	-	0.01
Current Portion of Leases	5.55	1.55	0.41	0.44	0.45
Unearned Revenue	0.4	6.97	7.49	3.36	4.47
Other Current Liabilities	12.1	53.79	25.7	10.61	5.38
Total Current Liabilities	231.62	205.09	112.44	58.22	27.61
Long-Term Debt	391.91	341.81	5.59	2.25	-
Long-Term Leases	56.53	5.04	5.23	4.42	1.39
Other Long-Term Liabilities	68.54	35.5	51.84	54.43	49.26
Total Long-Term Liabilities	516.99	382.35	62.66	61.1	50.64
Total Liabilities	748.61	587.44	175.1	119.32	78.25

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	479.96	414.01	304	252.45	124.18
Additional Paid-in Capital	-11.61	15.95	-42.8	-11.97	4.32
Accumulated Other Comprehensive Income	101.56	75.89	19.85	-0.38	-0.84
Retained Earnings	-154.54	-152.91	-179.61	-185.65	-126.09
Shareholders' Equity	415.38	352.94	101.44	54.44	1.57
Total Liabilities & Equity	1,164	940.38	276.54	173.77	79.82

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	467.11	360.16	11.88	7.11	1.85
Net Cash (Debt)	-325.24	79.84	72.07	72.05	14.17
Net Cash Growth	-	10.78%	0.02%	408.42%	-75.70%
Net Cash Per Share	-0.96	0.24	0.22	0.23	0.05
Book Value	415.38	352.94	101.44	54.44	1.57
Book Value Per Share	1.23	1.05	0.31	0.17	0.01
Tangible Book Value	-177.45	95.08	26.74	14.31	-38.94
Tangible Book Value Per Share	-0.52	0.28	0.08	0.05	-0.14

SEC Filings: 10-K · 10-Q